Dr. Jitendra Singh presents RSSDI diabetes awards in Bengaluru
Synopsis
Key Takeaways
India's diabetes research community gathered under one roof in Bengaluru on Friday, 20 November 2026 — and Union Science and Technology Minister Dr. Jitendra Singh was there to honour the best of them, presenting Fellowship and Appreciation awards for outstanding work in diabetes research and care at the 54th Annual Academic Conference of the Research Society for the Study of Diabetes in India (RSSDI).
India's diabetes burden and the science trying to turn the tide
The stakes of a conference like RSSDI's cannot be overstated. India carries one of the world's largest diabetes populations — a public-health reality that makes every advance in indigenous research and evidence-based clinical care a matter of national urgency. The Research Society for the Study of Diabetes in India has for decades served as the premier professional body channelling that urgency into structured science: annual conferences, peer exchange, and the kind of institution-building that moves the needle from awareness to action.
Bengaluru, home to a dense cluster of research institutions and medical colleges, regularly anchors national scientific gatherings of this scale. The city's scientific infrastructure makes it a natural stage for the country's endocrinologists, clinicians, and diabetes researchers to converge.
A minister with a science portfolio at a science event
Dr. Jitendra Singh's presence as the award-presenting authority is notable. As the minister holding independent charge of Science and Technology as well as Earth Sciences, and simultaneously serving in the Prime Minister's Office, his participation signals the government's intent to visibly back professional scientific societies and the researchers who populate them. Presenting fellowship awards — the highest recognition a professional society confers — connects federal science policy directly to the practitioners shaping clinical outcomes on the ground.
The government's interest in diabetes management has a formal policy lineage: the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), launched in 2010, established the institutional architecture for tackling non-communicable diseases including diabetes at scale. What RSSDI's annual conference does is feed the science that keeps that architecture relevant and evidence-based.
What recognition at RSSDI-54 means for the field
Fellowship and Appreciation awards at a body like RSSDI carry weight beyond the ceremony. They signal to the broader research community which lines of inquiry the field considers most consequential — in diabetes research specifically, that can shape funding priorities, clinical protocol updates, and the direction of the next generation of researchers. With successive governments encouraging professional societies to deepen indigenous research capacity, RSSDI's conference recommendations have the potential to inform updated national diabetes guidelines and future research funding calls.
India's diabetes challenge is not shrinking. The researchers and clinicians recognised in Bengaluru today are part of the country's best answer to it.